A. Egli

Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis

Karsten M. Borgwardt, K. Borgwardt, Bastian Alexander Rieck, 2020, Travel Medicine and Infectious Disease.

Islet Inflammation in Type 2 Diabetes (T2D): From Endothelial to β-Cell Dysfunction

M. Donath, J. Irminger, J. Ehses, 2007 .

SARS-CoV-2 in schools: genome analysis shows that concurrent cases in the second and third wave were often unconnected

U. Heininger, J. Bielicki, S. Fuchs, 2022, medRxiv.

Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations

M. Battegay, C. Marzolini, S. Tschudin-Sutter, 2020, Antimicrobial Agents and Chemotherapy.

Bacterial genome wide association study substantiates papGII of Escherichia coli as a patient independent driver of urosepsis

S. Tschudin-Sutter, M. Siegemund, J. Moran-Gilad, 2023, medRxiv.

Nosocomial human parainfluenza virus type 3 outbreak in immunocompromised patients, and possible lessons from the SARS-CoV-2 pandemic

S. Tschudin-Sutter, M. Osthoff, J. Halter, 2022, Journal of Hospital Infection.

Scarce data on skin microbiome in graft‐versus‐host disease after allogenic haematopoietic cell transplantation ‐ a systematic review

J. Halter, A. Egli, S. Müller, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations

M. Battegay, C. Marzolini, S. Tschudin-Sutter, 2020, Antimicrobial Agents and Chemotherapy.